Antidote Partners with SEQSTER to Accelerate Patient Identification & Enrollment for Clinical Trials

SAN DIEGO–(BUSINESS WIRE)–SEQSTER PDM Inc. (“SEQSTER”), the leading patient-centric healthcare technology company, and Antidote Technologies (“Antidote”), a digital health company that focuses on patient engagement to accelerate recruitment for clinical trials, today announced a partnership to enhance patient identification, improving trial timelines and enrollment outcomes for Pharma and Life Science companies with their fully integrated end-to-end solution. By leveraging the SEQSTER Operati
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks